Buscar
Mostrando ítems 21-30 de 816
Primary relapse site pattern in women with triple-negative breast cancer
(Elsevier B.V., 2015)
Terapias target más Quimioterapia comparado con Quimioterapia en Cáncer de mama triple negativo EC IV o recurrente. Revisión Sistemática y Metaanálisis
(Universidad Privada Antenor OrregoPE, 2021)
El cáncer de mama es el tumor maligno más frecuente en mujeres de
todo el mundo. Las pacientes con cáncer de mama triple negativo representan un
subgrupo de pronóstico desfavorable sobre todo en etapas avanzadas de la ...
Deregulation of VEGFR-2 and PDGFR expression and microvascular density in a triple-negative model of canine malignant mammary tumors with lymph node or lung metastasis
(2019-01-01)
Canine mammary tumors (CMT) represent the most common cancer in noncastrated female dogs. Interestingly, triple-negative tumors are the most common molecular subtype in female dogs. In this study, we proposed to evaluate ...
Stem cell-like Subtypes in Triple-Negative Breast Cancer.
(Academia Nacional de Medicina venezolana., 2022)
Glycans pave the way for immunotherapy in triple-negative breast cancer
(Cell Press, 2018-02)
The clinical efficacy of therapies targeting the PD-1/PD-L1 pathway is still limited. In this issue of Cancer Cell, Li and colleagues identify a PD-L1 glycosylation-based mechanism in triple-negative breast cancer that ...
Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas
(WILEY-BLACKWELL PUBLISHING, INC, 2009)
Aims: Histological grade is one of the most important prognostic factors in breast carcinomas, but poorly differentiated neoplasms still have quite heterogeneous biological behaviour, since they can be genetically classified ...
Combined calcitriol and menadione reduces experimental murine triple negative breast tumor
(Elsevier France-editions Scientifiques Medicales Elsevier, 2017-10)
Background Calcitriol (D) or 1,25(OH)2D3 inhibits the growth of several tumor cells including breast cancer cells, by activating cell death pathways. Menadione (MEN), a glutathione-depleting compound, may be used to ...
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
(Seguro Social de Salud (EsSalud)PE, 2018)
El cáncer de mama triple negativo carece de marcadores pronósticos y predictivos. Se utiliza un estudio fosfoproteómico de alto rendimiento para construir una taxonomía funcional del cáncer de mama triple negativo. En ...